FDA Issues Notice of Nationwide Recall of Common Anxiety Medication

A U.S. company is recalling Xanax, or alprazolam, because it failed to meet dissolution specifications, according to an FDA notice.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The maker of Xanax is recalling a batch of the widely prescribed anxiety medication across the United States, according to a notice published by the Food and Drug Administration (FDA).

U.S.-based pharmaceutical company Viatris Inc. is recalling Xanax, or alprazolam, because it failed to meet dissolution specifications, says the FDA report uploaded to its website this week.